Tivic Health Systems, Inc, a commercial-phase health technology company that develops and commercializes bioelectronic medicine, announced it has received recertification of ISO 13485, the international standard for medical device quality systems. The company also announced the recertification of ClearUP under the European Union Medical Device Certificate (CE-Mark).
“Congratulations to the team for successfully achieving these recertifications.”
“These recertifications support our goals to grow the product pipeline in bioelectronic medicine and expand market access,” said Jennifer Ernst, CEO of Tivic. “Congratulations to the team for successfully achieving these recertifications.”
Also Read: Untapped potential of machine learning techniques for Parkinson’s Disease research and healthcare
ISO 13485 is an international standard for quality management systems (QMS) and applies to medical device companies involved in designing, manufacturing, and commercializing medical device products. ISO 13485 has been harmonized as a basis for the implementation of quality management methods into government regulations on medical devices in countries around the world, including the European Union.
Tivic is a commercial-phase health technology company delivering non-invasive bioelectronic treatments that provide consumers with a choice in the treatment of inflammation and certain other related conditions.
SOURCE: Businesswire